Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q3 2019

Baupost Group

Portfolio at the end of Q3 2019, from the 13F filed November 13, 2019. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Liberty Global LBTYK · history 11.8% $1.05B 43,958,295 $23.79 Q3 2018 Add 5%
Viasat VSAT · history 11.7% $1.03B 13,732,068 $75.32 Q2 2013 or earlier No change
Fox Corporation FOXA · history 9.8% $861.6M 27,322,720 $31.54 Q1 2019 No change
eBay EBAY · history 7.3% $648.9M 16,646,000 $38.98 Q4 2018 Reduce 31%
Cheniere Energy LNG · history 7.2% $639.4M 10,139,133 $63.06 Q1 2014 Reduce 5%
Bristol-Myers Squibb BMY · history 5.7% $507.1M 10,000,000 $50.71 Q1 2019 Reduce 23%
CBS CBS · history 5.5% $484.4M 12,000,000 $40.37 Q4 2018 Add 20%
Qorvo QRVO · history 4.8% $421.2M 5,681,181 $74.14 Q1 2017 Reduce 35%
Tesla TSLA.CV · convertible notes · history 3.4% $303.5M 300,000,000 prn Q1 2018 No change
DigitalBridge CLNY · history 3.4% $299.1M 49,687,370 $6.02 Q2 2018 No change
PG&E PCG · history 2.8% $245.0M 24,500,000 $10.00 Q1 2018 No change
Nexstar Media Group NXST · history 2.3% $204.6M 2,000,000 $102.31 Q4 2018 Add 43%
Univar Solutions UNVR · history 2.2% $197.2M 9,500,000 $20.76 Q3 2018 No change
Liberty Global LBTYA · history 2.1% $189.5M 7,657,205 $24.75 Q3 2018 Add 3%
Theravance Biopharma TBPH · history 2.1% $181.3M 9,309,168 $19.48 Q2 2014 No change
Fox Corporation FOX · history 2.0% $179.2M 5,680,307 $31.54 Q1 2019 No change
McKesson MCK · history 2.0% $178.5M 1,306,011 $136.66 Q3 2017 Reduce 50%
Translate Bio TBIO · history 2.0% $172.2M 17,544,239 $9.82 Q2 2018 Add 98%
Synchrony SYF · history 1.9% $170.6M 5,003,981 $34.09 Q3 2016 Reduce 46%
Takeda Pharmaceutical TAK · history 1.8% $162.3M 9,434,803 $17.20 Q1 2019 No change
Nuance Communications NUAN · history 1.5% $134.5M 8,245,456 $16.31 Q3 2019 Buy
Atara Biotherapeutics ATRA · history 1.3% $117.3M 8,308,900 $14.12 Q4 2014 Add 19%
Cencora COR · history 1.1% $96.0M 1,166,299 $82.33 Q3 2017 Reduce 47%
Akebia Therapeutics AKBA · history 1.1% $95.9M 24,471,453 $3.92 Q4 2018 No change
Veritiv VRTV · history 0.7% $64.4M 3,564,439 $18.08 Q3 2014 No change
Antero Resources AR · history 0.7% $63.7M 21,087,791 $3.02 Q3 2014 Reduce 26%
Vista Energy VIST · history 0.4% $31.9M 6,175,000 $5.17 Q3 2019 Buy
Theravance Biopharma TBPH.CV · convertible notes · history 0.3% $27.7M 30,000,000 prn Q4 2016 No change
Cars.com CARS · history 0.3% $26.9M 3,000,000 $8.98 Q3 2019 Buy
Trilogy Metals TMQ · history 0.2% $20.0M 12,182,568 $1.64 Q2 2013 or earlier Reduce 11%
Gossamer Bio GOSS · history 0.2% $15.9M 967,171 $16.41 Q1 2019 Reduce 24%
Paratek Pharmaceuticals PRTK · history 0.1% $10.3M 2,394,498 $4.32 Q4 2014 No change
32 positions100.0%$8.83B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2019, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Media & telecom45.3%
Health care17.7%
Consumer discretionary10.8%
Energy8.3%
Technology6.6%
Financials & real estate5.3%
Industrials3.0%
Utilities2.8%
Materials0.2%

What changed from Q2 2019

← Q2 2019 Q4 2019 →